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Abstract
Background: Gram negative infection is a major determinant of morbidity and survival. Traditional teaching suggests that
burn wound infections in different centres are caused by differing sets of causative organisms. This study established
whether Gram-negative burn wound isolates associated to clinical wound infection differ between burn centres.
Methods: Studies investigating adult hospitalised patients (2000–2010) were critically appraised and qualified to a levels of
evidence hierarchy. The contribution of bacterial pathogen type, and burn centre to the variance in standardised incidence
of Gram-negative burn wound infection was analysed using two-way analysis of variance.
Primary Findings: Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumanni, Enterobacter spp., Proteus spp.
and Escherichia coli emerged as the commonest Gram-negative burn wound pathogens. Individual pathogens’ incidence
did not differ significantly between burn centres (F (4, 20) = 1.1, p = 0.3797; r2 = 9.84).
Interpretation: Gram-negative infections predominate in burn surgery. This study is the first to establish that burn wound
infections do not differ significantly between burn centres. It is the first study to report the pathogens responsible for the
majority of Gram-negative infections in these patients. Whilst burn wound infection is not exclusive to these bacteria, it is
hoped that reporting the presence of this group of common Gram-negative ‘‘target organisms’’ facilitate clinical practice
and target research towards a defined clinical demand.
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Introduction
1.1 Background and Rationale
Gram-negative infection is a global health concern [1]. Several
advances have been registered in the field of intensive care,
ventilatory support, skin substitution and fluid balance [2].
However, infection has emerged as a major, often unmitigated
complication in burn injury, which incurs significant morbidity,
mortality and healthcare cost [3]. Management of acute infection
in thermal injury presents unique challenges in terms of clinical
diagnosis and rapid institution of effective antimicrobial chemo-
therapy. Clinical diagnosis is hampered by thermal injury-induced
hyperpyrexia, immune suppression, and systemic inflammatory
response syndrome [3,4]. These factors make clinical diagnosis
difficult and promote infection [5]. It is, however, well-established
that Gram-negative pathogens predominate beyond the early post-
burn period [5]. Centres for Disease Control (USA), the British
Society of Antimicrobial Chemotherapy, and its European and
Asian Counterparts provide extensive documentation regarding
aetiological profiles and incidences of the major protagonists in
other disease, such as pneumonia and urinary tract infection [6,7].
This data, in turn, provides aetiological targets for rationalised
expedited, targeted antimicrobial prescribing, infection control,
and antimicrobial development [8]. Traditional teaching is based
on incidence data that is non-standardised and difficult to
compare; it maintains that Gram negative burn wound isolates
differ between burn centres [9–11].
Objective
The purpose of this study is to establish whether the isolates
associated with clinical Gram negative burn wound infection differ
between burn centres. This study also sought to establish
standardised incidence rates for the organisms identified.
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Methods
3.1 Aim Construct
The terms of reference in relation to this systematic review and
meta-analysis (File S1) in Patient Intervention Comparator and
Outcome (PICO) format, are reported in File S2, in conformance
to pre-validated criteria [12].
3.2 Literature Search
A combination of National Library of Medicine (NLM) Medical
Subject Heading (MeSH) Descriptor Data Browser terms were
used to increase search sensitivity [13]. These were used in a first
generation electronic search whose results were manually screened
for relevance (File S3). The first generation search was performed
using the OVID-SP and PUBMED platforms (File S4). The
second generation search involved manual back-referencing and
Web of Knowledge. Results of the electronic literature search are
reported extensively in File S5.
3.3 Inclusion/Exclusion Criteria
This study specifically adhered to the PICO-specified terms of
reference as inclusion criteria (File S2). In order to enable data
pooling and anlalysis, only primary literature investigating adult
hospitalised burn patients only was analysed, and studies including
patients with delayed transfer were excluded from this analysis.
Primary literature published between 2000 and 2010, in English,
studying adult locally-injured hospitalised humans only was
included. The limitations of this approach are fully acknowledged,
and applicability of the study to other populations is debated in the
discussion section.
3.4 Reporting of the Systematic Review and Evidence-
based Process
PRISMA guidelines were applied to report the systematic
review and evidence-based process. The retrieval process reported
heterogeneous methodologies in the primary literature but no
randomised controlled trials (RCT’s), requiring these guidelines to
be adapted. Systematic review of studies other than RCTs is not
new [14]. To ensure comparability and adequate data selection
rigorous critical appraisal [15,16] was applied to determine the
quality of the primary studies retrieved, and ensure inclusion of
comparable, current, valid and relevant evidence [17]. Pre-
validated critical appraisal tools were employed on the primary
research to achieve significant depth of appraisal [12,18]. Two
researchers, arbitrated by a third, independently performed critical
appraisal. The Oxford Centres for Evidence Based Medicine
‘‘levels of evidence’’ framework was used to provide a framework
to reflect the robustness of individual studies [19]. The literature
retrieval process is reported in detail (Files S5, S6).
3.5 Operational Definitions and Summary Measures
Primary literature reported various measures of incidence,
therefore incidence rates were standardised as number of new
cases per 1000 patient-years [20]. As a working definition, an
organism was defined as causative if it could be discerned from the
study that the organism was isolated from wound in the presence
of clinical infection. ‘‘New’’ was defined as the first documentation
of an organism, thereby excluding relapse or re-infection. Clinical
diagnosis of infection was based on reconciliation of primary
literature to the definitions of Greenhalgh et al. [21]. For the
purposes of this study, studies reporting on patients whose transfer
to the definitive treatment centre was delayed (non-immediate)
were excluded.
3.6 Statistical Analysis
Statistical analysis was performed with Graphpad Prism v5 for
windows (CA, USA). The contribution of the two independent
variables under consideration (bacteria, burn centre) to the
variance in standardised incidence of Gram-negative burn wound
pathogens was analysed using two-way analysis of variance
(ANOVA). Statistical significance was assumed when p,0.05.
Figure 1. PRISMA-style scheme reporting the literature retrieval and selection strategy arriving to the final 7 studies whose data
could be pooled for statistical analysis.
doi:10.1371/journal.pone.0095042.g001
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Statistical analysis was performed blinded, by a qualified
statistician (LC).
Results
4.1 Literature Retrieval and Critical Appraisal
Thirty four studies were retrieved by the initial literature search
(Figure 1). Narrative critical appraisal is provided in extensive
detail in File S7. Of these studies, 20 did not conform to the
inclusion criteria and were excluded (File S6). Fourteen studies
were included for critical appraisal (Table 1). A further 5 studies
did not conform to operational definitions (section 3.3). ‘‘Strength
of the evidence’’ underpinning the remaining studies was
evaluated by critical appraisal and is reported in Table 2. Two
further studies [22,23] investigated primary incidence over week 1
post-burn only. Because of this methodological heterogeneity, their
results could not be pooled or confidently compared to the rest of
the literature. Standardised incidence data from the remaining 7
studies (Table 2) was extracted and pooled (Figure 2). The
geographic location of the burn centres from which the data was
pooled is reported in Figure 3.
4.2 Data Extraction
Data from clinically and statistically comparable studies was
transformed to a standardised incidence rate (n new Gram
negative BWI per 1000 patient-years, Table 2). Data-distribution
of the standardised incidence rates for each pathogen in the
Table 1. Literature Included for Critical Appraisal.
n Reference Design Aim Sample
1 [50] Retrospective study ‘‘To determine the bacterial profile and antimicrobial susceptibility of the isolates and to
describe the change in trends over the study period.’’
665
2 [51] Retrospective Cohort ‘‘To determine the incidence and cause of nosocomial infections in all patients admitted to
our burn intensive care unit (BICU) over a 5-year period’’
76
3 [52] Prospective Describe a specially designed computer system for the analysis of data, and report the
results from the first 3 years of using the system for routine registration of infection in a
consecutive series of burn patients.
83
4 [9] Retrospective ‘‘To determine the changing patterns and emerging trends of bacterial isolates and their
antimicrobial susceptibilities’’
759
5 [53] Retrospective cohort ‘‘To analyse the bacterial isolates from the wounds of patients admitted to the Burns
Unit and to determine the sensitivity pattern of the commonly cultured organisms’
336
6 [11] Prospective Study ‘‘To investigate the profile of micro-organisms and resistance to antimicrobial agents
in a tertiary referral burn centre’’
113
7 [54] Retrospective Study ‘‘To determine the bacterial profile and antibiotic susceptibility pattern of burn
isolates at the Queen Elizabeth Central Hospital (QECH), Blantyre’’
317
8 [23] Prospective ‘‘To determine nosocomial infections in the Tohid Burn Centre in Tehran, Iran’’ 582
9 [22] Prospective Clinical
Audit
This prospective clinical audit investigated the primary incidence of BWI between the
usual burn patients […] and a number of survivors from the Bali bombings during
a 3-month audit.
64
10 [55] Retrospective Cohort
Study
‘To document burn wound infection and problems faced by the clinicians’ 71
11 [56] Narrative review An index case of pseudomonal BWI is reported followed by a narrative review of
incidence mortality, risks and prognosis
N/A
12 [57] Narrative Review A narrative review describing risk two Acinetobacter baumanni outbreaks, and risk
factors [aim not explicitly stated]
72
13 [33] Case-control arm
Retrospective
Cohort Arm
‘‘This study was conducted to determine the risk factors for acquisition of
imipenem-resistant Pseudomonas aeruginosa (IRPA) in the burn unit.’’
370
14 [6] Prospective
Cohort Study
‘To determine accurate infection rates, risk factors for infection, and the
percentage of infections.’
157
doi:10.1371/journal.pone.0095042.t001
Figure 2. Box-whisker plot reporting data dispersion for the
standardised incidence of Gram-negative burn wound injury in
civilian adult hospitalised patients. Data shown represents
mean61SD.
doi:10.1371/journal.pone.0095042.g002
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identified Gram-negative BWI profile is represented by a box-
whisker plot (Figure 1). Descriptively, all these studies reported a
similar set of bacteria consisting of P. aerugionsa, K. pneumoniae, E.
coli, Enterobacter spp. and Proteus spp. as the commonest Gram-
negative pathogens to be isolated from clinically infected burn
wounds in the burn centres studied. Standardised incidences
reported in this study report Pseudomonas aeruginosa is the
commonest BWI pathogen, but the incidence varied widely and
differs significantly from the preceding literature [24].
4.3 Statistical Analyses
The majority of infections, 60.2%612.5% (mean61 SD) were
Gram-negative. A mean incidence rate of 156 new Gram-negative
BWI per 1000 patient-years was calculated. Mixed infection
accounted for 10.363.7% (mean61 SD) of infection. Two-way
ANOVA reported that identity of the bacterial species (indepen-
dent variable) was responsible for 47.8% of the total variance (F (5,
20) = 4.13). This was highly statistically significant (p = 0.0098).
The same statistical method also reported that Burn Centre
accounted for 9.84% of the total variance (F (4, 20) = 5.11), but
this effect was not statistically significant (p = 0.3797).
Discussion
This study studied primary literature to establish whether the
isolates associated with clinical Gram negative burn wound
infection differ between burn centres. Burn wound infection has
traditionally been a difficult area for the clinician, and one of the
primary reasons is the difficulty in knowing which organisms to
target. This study established that organisms causing Gram-
negative burn wound infection do not differ significantly between
burn centres. Analysis of the standardised data confirm, within this
study’s limitations, the principal hypothesis that the organisms
causing Gram-negative burn wound infection are similar, regard-
less of geographic location of the treating centre (p,0.05). This
finding presents a significant departure from traditional teaching
regarding the behaviour of infected burn wounds (section 1). The
lack of standardised data reporting may be one possible
explanation for this discord [25]. In contrast, aetiological profiles
and incidences of the major protagonists in other disease such as
urinary tract infection have long been established, and are
constantly reviewed [6,7]. Establishing the organisms that
commonly cause Gram-negative infection in burn wounds may
confer to acute burns patients the long-term benefits enjoyed by
these other common diseases, such as rationalised, expedited,
targeted antimicrobial development, prescribing, infection control,
and surveillance of resistance patterns. These findings, integrated
with local data regarding susceptibility patters, may facilitate the
formulation of ‘‘first line’’ antibiotic treatment strategies, and
increase probabilities of therapeutic efficacy. For example,
worldwide resistance to commonly used broad spectrum antibiot-
ics such as ceftriaxone is common (from 16.3% E. coli to 64% of
Acinetobacter strains studied) [26].
Identifying this set of bacteria may also have implications on
defining research strategies in drug redevelopment. Only up to
1.4% of isolates from across the species identified are resistant to
colistin, emphasising the usefulness of this antibiotic as a drug of
last resort [26]. These observations lend further credence to the
strong interest of this venerable class’s redevelopment via semi-
synthetic chemistry approaches. The approach to identifying a
common set of bacteria responsible for burn wound infection has
already borne translational fruit. Recently, an in-depth analysis for
commonalities of biochemical and virulence mechanisms involved
in the aetiology of infection with these organisms identified that
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substantial production of bradykinin is common to all these
pathogens and leads to enhanced vascular permeability and
sequestration of macromolecules. Based on this principle, we
recently published evidence of a novel, size-based paradigm for
drug targeting in infection [27]; statistically optimised a bior-
esponsive polymeric payload carrier to achieve this goal [28];
proposed a novel class of macromolecular antimicrobial agents
capable of locally triggered enzymatic activation at the infected
site, retaining antimicrobial potency to match the conventional
clinical equivalent whilst significantly reducing in vivo toxicity
[29,30].
Ample evidence exists to support the notion that morbidity,
mortality and quality of life outcomes in burn patients is associated
to the organisms identified in this study. For example, wound
infection with P. aeruginosa, E. coli, and K. pneumoniae wound is an
independent predictor of mortality [3,31]. These bacteria also
promote failure of healing [32] which is of major consequence to
the management of extensive burn wounds by serial excision
where time to healing is essential and donor sites for grafting come
at a premium. Moreover, specific risk factors associated to burn
wound infection with these organisms have been identified [33–
35], and modification of management practices may lower
infection rates resulting in improved outcomes. The importance
of identifying this set of organisms as the prime perpetrators of
Gram-negative burn wound infection, regardless of the treating
centre, is therefore apparent.
P. aeruginosa (Figure 2) exhibits an interesting, wider dispersion of
dispersion of data compared to the other organisms. A possible
explanation lies in the presence of an outlier data set [11] (Table 2),
hence the long superior whisker for the P. aeruginosa plot in
Figure 2. However ANOVA, is remarkably robust to moderate
departures from normality caused by outlier data sets. One
possible explanation for this outlier may lie in the susceptibility of
the standardised incidence of P. aeruginosa to the overall infection
rate reported from the relative burn centre. In fact, the overall
infection rate reported from this centre is also high [11].
Such a study presented unique difficulties. Mere presence of
organisms on a wound does not imply infection. Histological
documentation of infection into viable tissue may secure the
diagnosis. However, in practice, few if any centres worldwide have
the substantial resources required to fulfil laboratory diagnostic
criteria such as routine microbiological tissue histology and
electron microscopy on a daily basis. Moreover, definitions of
burn wound infection underpinned by these (tissue biopsy and
electron microscopy) laboratory investigations are largely consid-
ered dated [36,37]. As a working definition, an organism was
defined as causative if it could be discerned from the primary
literature that the organism/s was isolated from the wound in the
presence of clinical infection. Clinical diagnosis of infection was
based on reconciliation of primary literature data to the definitions
of Greenhalgh et al. [21]. Studies including re-infection or relapse
in their incidence rates were excluded. Whilst the clinical
surrogates presented in these definitions may be less specific then
exhaustive (but rarely performed) laboratory investigations, the
approach presented herein would reduce the potential bias
presented by the resources available to the researchers producing
the primary literature.
As no RCTs were identified, the conduct of this review was
adapted to consider the pooling of data from primary studies with
heterogeneous methodologies. Systematic review of studies other
than RCTs is well-established in the literature [21]. Therefore, a
rigorous critical appraisal process qualified the ‘‘strength of the
evidence’’ underpinning the primary data included in the
statistical analysis. The critical appraisal process also facilitated
the reconciliation of the primary literature to the operational
definitions, ensuring comparability of the studies. Such an
evidence-based approach is not new [12]. Quality of the evidence
provided by the primary literature was limited (Table 2), justifying
the use of an evidence-based methodology combined to the
systematic review process. Since the burn centres in the primary
literature were geographically separate and did not have
overlapping catchment areas, it was reasonable to assume that
‘‘no interaction’’ occurred between the two independent variables
studied.
The selection of adequate inclusion and exclusion criteria was
challenging. A rigorous approach in data retrieval was observed
and catalogued to prevent retrieval bias. In order to minimise the
possibility data contamination with lurking variables, stringent
criteria were applied. Evidence exists that delayed transfer may
influence the bacteriological flora burned patients [38]. Studies
concur that delayed presentation may alter the pathological flora
on a burn wound [3,39]. Military patients may pass through
multiple facilities to the definitive site of treatment, and this delay
presented a plausible lurking variable [38,40]. This data was
therefore excluded purely as a necessity to safeguard methodo-
logical rigour rather than implying a difference between military
and civilian populations. In fact, data from Operation Iraqi
Freedom and Operation Enduring Freedom suggests that similar
bacterial flora is present in such patients, [38,40,41]. Indeed
Figure 3. Geographic distribution of the centres from which studies were critically appraised. The study design and sample size are
provided in figure 2.
doi:10.1371/journal.pone.0095042.g003
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primary studies describing civilian injuries [22,42] were also
excluded for similar reasons.
A five to ten year cut-off for the retrieval of primary data is well-
established in evidence-based methodology [12,43]. Such time-
limits for the inclusion of primary data in evidence-based medicine
harks back to the main works of Archie Cochrane and DL Sackett
[44,45], affirmed in the Sicily statement for evidence-based
research [17] and cited in multiple works since then [46–48].
Moreover until the 1980’s burn wounds were treated by the
exposure method, with application of topical antimicrobials to the
burn wound surface and gradual debridement with immersion
hydrotherapy [24]. Thereafter, early burn wound excision and
wound closure became the focal point of burn wound manage-
ment, accompanied by a change from immersion hydrotherapy to
showering hydrotherapy, and a consequent decrease in the rate of
burn wound infection [24]. It is also well-established that early
excision has reduced the incidence of invasive infection, as
underscored by key publications immediately preceding our cut-
off point for retrieval of primary literature. Pruitt et al. in
particular, assert that the change to early excision and grafting
significantly changed, both qualitatively and quantitatively, the
incidence and identity of organisms causing these infections and
their timing [38,49].
It was assumed that by the year 2000, this method of treatment
would have been well-established, coinciding with the cut-off point
determined by the evidence-based methodology. However, it is
acknowledged that such arbitrary cut-off points may have led to
retrieval bias in selection of primary literature.
Conclusion
This study is the first to report that organisms causing clinical
Gram-negative burn wound infection do not differ significantly
between burn centres. Therefore, these findings establish a ‘‘target
set’’ of Gram-negative pathogens for antimicrobial development
and timely, effective treatment. P. aerugionsa, K. pneumoniae, E. coli,
Enterobacter spp. and Proteus spp. were identified as the commonest
Gram-negative pathogens to be isolated from clinically infected
burn wounds regardless of the treating centre. It is of course
acknowledged that other bacteria may infect the burn wound and
it is especially important to monitor emerging infections [51].
However, we hope that finding a ‘‘target’’ set of pathogens may
contribute to timely clinical treatment, effective, and clinically
oriented antibiotic development. The threat posed by multi-drug
resistant pathogens continues to increase, however research and
clinical management in this specialist field remain poorly funded,
fragmented and oftentimes reported in isolation. The paucity of
relevant literature highlighted in this study illustrates the dire
necessity for further epidemiological multi-disciplinary collabora-
tion. We augur that the identification of a common aetiological
Gram-negative burn wound profile will be a first step in this
direction.
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